Document Classification

Section Type: RESULTS

Text: Levosimendan produced a statistically significant increase in LVEF (28 + / -5 % vs. 33 + / -3 %), Sm (6. 5 + / -1. 2 cm/s vs. 7. 4 + / -0. 9 cm/s), DT (120 + / -10 ms vs. 140 + / -15 ms), and Em (7. 5 + / -0. 4 cm/s vs. 8. 1 + / -0. 5 cm/s) and significant decrease in E/A ratio (2. 1 + / -0. 3 vs. 1. 7 + / -0. 4) and SPAP (55 + / -5 mmHg vs. 40 + / -7 mmHg).